troglitazone has been researched along with Recrudescence in 1 studies
Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The primary aim of the TRIPOD trial is to test the hypothesis that chronic administration of troglitazone to nondiabetic women with prior gestational diabetes mellitus (GDM) will improve whole-body insulin sensitivity and reduce the incidence of non-insulin-dependent diabetes (NIDDM)." | 2.69 | TRIPOD (TRoglitazone In the Prevention Of Diabetes): a randomized, placebo-controlled trial of troglitazone in women with prior gestational diabetes mellitus. ( Azen, SP; Berkowitz, K; Buchanan, TA; Kjos, S; Peters, RK; Xiang, A, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azen, SP | 1 |
| Peters, RK | 1 |
| Berkowitz, K | 1 |
| Kjos, S | 1 |
| Xiang, A | 1 |
| Buchanan, TA | 1 |
1 trial available for troglitazone and Recrudescence
| Article | Year |
|---|---|
TRIPOD (TRoglitazone In the Prevention Of Diabetes): a randomized, placebo-controlled trial of troglitazone in women with prior gestational diabetes mellitus.
Topics: Adolescent; Adult; Blood Glucose; Carotid Stenosis; Chromans; Diabetes Mellitus, Type 2; Double-Blin | 1998 |